“The index rose 0.97% to 52,017, with gains broadening through the session as cash market liquidity improved,” analysts noted. This recovery comes after the Nikkei 225 experienced a sharp decline of over 3,700 points over two days, reflecting significant market volatility.
The rebound was primarily fueled by strong performances in the pharmaceutical and metals sectors. Notably, Sumitomo Dainippon surged by 6.70%, Astellas Pharma increased by 5.46%, and Sumitomo Metal Mining rose by 5.18%. These gains helped offset losses from other companies, including Nintendo Co, which saw a decline of 4.12%.
Market observers have pointed out that the USDJPY exchange rate, hovering near 160, indicates a weaker yen. A weaker yen tends to lift exporters’ reported revenues and margins, which can support indices like the Nikkei 225.
Despite the positive movement, Japan has issued warnings regarding potential actions against disorderly foreign exchange moves, highlighting the ongoing concerns about currency fluctuations impacting the market.
“The market continues to be very noisy and difficult, but I think at this point in time you need to be very cautious about getting overly aggressive with any position size in any index around the world,” one expert cautioned, reflecting the heightened uncertainty in global markets.
As the Nikkei 225 closed up 501 points on Tuesday, volatility remains elevated. Investors are advised to stay alert as the situation develops, with analysts closely monitoring both market trends and geopolitical factors that could influence future movements.
Overall, while the rebound is a positive sign, the underlying volatility and external pressures suggest that caution remains paramount for investors navigating this turbulent landscape.
